← Back to Clinical Trials
Recruiting NCT05988190

NCT05988190 Contextual Word Learning in Children With Developmental Language Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05988190
Status Recruiting
Phase
Sponsor Binghamton University
Condition Developmental Language Disorder
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2024-04-17
Primary Completion 2026-04-01

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 11 Years
Study Type INTERVENTIONAL
Interventions
Contextual Word Learning Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2024-04-17 with a primary completion date of 2026-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Many children have developmental language disorder, which makes it difficulty to learn language, including vocabulary, and results in ongoing academic and social difficulties. Despite the fact that most words are learned in context without direct teaching, we know very little about how children with developmental language disorder learn words in context. This project will combine, for the first time, two strategies which improve contextual word learning in children with typical development, and test their effect in both typically developing children, and those with developmental language disorder. The results will provide timely information that will contribute to evidence based practice for contextual word learning in children with developmental language disorder.

Eligibility Criteria

Inclusion Criteria: * Aim 1: Standard Score \> 90 on Clinical Evaluation of Language Fundamentals - Core Test Language Battery administered in 2nd grade * Aim 2: Standard Score \<= 85 on Clinical Evaluation of Language Fundamentals - Core Test Language Battery administered in 2nd grade Exclusion Criteria: * hearing impairment * uncorrected visual impairment

Contact & Investigator

Central Contact

Dawna M Duff, PhD

✉ dduff@binghamton.edu

📞 6077774676

Principal Investigator

Dawna M Duff

PRINCIPAL INVESTIGATOR

Binghamton University

Frequently Asked Questions

Who can join the NCT05988190 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 11 Years, studying Developmental Language Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05988190 currently recruiting?

Yes, NCT05988190 is actively recruiting participants. Contact the research team at dduff@binghamton.edu for enrollment information.

Where is the NCT05988190 trial being conducted?

This trial is being conducted at Johnson City, United States.

Who is sponsoring the NCT05988190 clinical trial?

NCT05988190 is sponsored by Binghamton University. The principal investigator is Dawna M Duff at Binghamton University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology